Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$140K Buy
+108,218
New +$149K ﹤0.01% 3520
2025
Q4
– Sell
-15,436
Closed -$25K – 3658
2025
Q3
$25K Buy
+15,436
New +$32.3K ﹤0.01% 2682
2024
Q1
– Sell
-12,144
Closed -$154K – 2753
2023
Q4
$154K Buy
12,144
+1,952
+19% +$20.3K ﹤0.01% 1836
2023
Q3
$105K Sell
10,192
-86,503
-89% -$1M ﹤0.01% 1942
2023
Q2
$1.27M Buy
+96,695
New +$1.18M 0.01% 806
2023
Q1
– Sell
-64,767
Closed -$545K – 2887
2022
Q4
$545K Buy
+64,767
New +$616K 0.01% 1349

Other funds holding LUNG

HRT Financial's LUNG Position: Q2 2026 in Review

HRT Financial opened a new position in Pulmonx (LUNG) in Q2 2026: 108,218 shares worth $140K. The stake represents ﹤0.01% of the portfolio and ranks #3520 among its holdings. This is a return to the name: HRT Financial previously reported a position in LUNG as recently as Q3 2025.

HRT Financial first reported a position in LUNG in Q4 2022 and has held it in 6 quarters since. The position peaked at $1.27M in Q2 2023. 107 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • HRT Financial held 108,218 shares of Pulmonx worth $140K as of Q2 2026.
  • Pulmonx was a new HRT Financial position in Q2 2026.
  • Pulmonx made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3520 holding.
  • HRT Financial first reported a position in Pulmonx in Q4 2022 and has held it in 6 quarters since.
  • HRT Financial's Pulmonx position peaked at $1.27M in Q2 2023.
  • 107 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.